These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 24769653

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.
    J Natl Cancer Inst; 2003 Jan 01; 95(1):46-52. PubMed ID: 12509400
    [Abstract] [Full Text] [Related]

  • 23. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.
    JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153
    [Abstract] [Full Text] [Related]

  • 24. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Ge Y, Christensen P, Luna E, Armylagos D, Schwartz MR, Mody DR.
    Cancer Cytopathol; 2017 Aug 05; 125(8):652-657. PubMed ID: 28574670
    [Abstract] [Full Text] [Related]

  • 25. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D, Zhang H, Li J, Austin M, Wang T, Pradhan D, Zhao C.
    J Am Soc Cytopathol; 2020 Aug 05; 9(6):550-555. PubMed ID: 32475726
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.
    Eur J Gynaecol Oncol; 2004 Aug 05; 25(5):577-84. PubMed ID: 15493169
    [Abstract] [Full Text] [Related]

  • 34. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
    Sharpless KE, O'Sullivan DM, Schnatz PF.
    J Low Genit Tract Dis; 2009 Apr 05; 13(2):72-8. PubMed ID: 19387126
    [Abstract] [Full Text] [Related]

  • 35. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J, Morelos HPV Study Collaborators.
    Salud Publica Mex; 2002 Apr 05; 44(4):335-44. PubMed ID: 12216521
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution.
    Patadji S, Li Z, Pradhan D, Zhao C.
    Cancer Cytopathol; 2017 Mar 05; 125(3):205-211. PubMed ID: 28060456
    [Abstract] [Full Text] [Related]

  • 38. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion.
    Wu HH, Allen SL, Kirkpatrick JL, Elsheikh TM.
    Diagn Cytopathol; 2006 Oct 05; 34(10):707-10. PubMed ID: 16955480
    [Abstract] [Full Text] [Related]

  • 39. Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management.
    Cox JT.
    Obstet Gynecol Surv; 2006 Jun 05; 61(6 Suppl 1):S15-25. PubMed ID: 16729900
    [Abstract] [Full Text] [Related]

  • 40. Detection of high-risk human papillomavirus (HPV) DNA by Hybrid Capture II in women referred due to atypical glandular cells in the primary screening.
    Oliveira ER, Derchain SF, Rabelo-Santos SH, Westin MC, Zeferino LC, Campos EA, Syrjanen KJ.
    Diagn Cytopathol; 2004 Jul 05; 31(1):19-22. PubMed ID: 15236259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.